This study investigates metastatic solid tumors. The purpose of this study is to explore the effects of an investigational medication on these tumors.
The study evaluates the safety and possible effectiveness of the investigational medication in shrinking tumors.
- Who can participate: Adults aged 18 and older with pancreatic, breast, or other solid tumors not cured by standard therapies, and children aged 12-17 with solid tumors other than rhabdomyosarcoma may participate.
- Study details: Participants will take the investigational medication by mouth.